Phosphatidylinositol turnover in mitogen-activated lymphocytes. Suppression by low-density lipoproteins
- 15 October 1980
- journal article
- research article
- Published by Portland Press Ltd. in Biochemical Journal
- Vol. 192 (1) , 91-98
- https://doi.org/10.1042/bj1920091
Abstract
Low-density lipoproteins [LDL] inhibit phytohemagglutinin-enhanced turnover of phosphatidylinositol [PI] in human peripheral lymphocytes. Turnover was assessed by 32P incorporation into phospholipids and by a loss of 32P from [32P]PI. Inhibition of lipid turnover by LDL is not the result of a change in the amount of phytohemagglutinin required for maximum cellular response. Neither phytohemagglutinin nor LDL influence 32P incorporation into phosphatidylethanolamine and phosphatidylcholine during the 1st 60 min after mitogenic challenge. The extent of inhibition of PI turnover by LDL depends on the concentration of LDL present in the incubation medium; 50% of maximum inhibition occurs at a LDL protein concentration of 33 .mu.g/ml and maximum inhibition occurs at LDL protein concentrations above 100 .mu.g/ml. Phytohemagglutinin stimulates 32P incorporation into PI, PI phosphate and PI bisphosphate. However, LDL abolish 32P incorporation into PI without affecting incorporation into PI phosphate and PI bisphosphate. The ability of LDL to inhibit phytohemagglutinin-induced PI turnover is mimicked by EGTA [ethylene glycol bis[2-aminoethyl ether]-N,N''-tetraacetic acid]. Inhibition of LDL by phytohemagglutinin-induced 32P incorporation into PI correlated directly with inhibition by LDL of Ca2+ accumulation. Ca2+ accumulation and turnover of PI may be coupled responses in lymphocytes challenged by mitogens. The step in PI metabolism that is sensitive to LDL and that is coupled to Ca2+ accumulation is release of [32P]PI from PI.This publication has 29 references indexed in Scilit:
- Interaction of plasma lipoproteins with erythrocytes. II. Modulation of membrane-associated enzymesBiochimica et Biophysica Acta (BBA) - Biomembranes, 1979
- Interaction of plasma lipoproteins with erythrocytes. I. Alteration of erythrocyte morphologyBiochimica et Biophysica Acta (BBA) - Biomembranes, 1979
- Identification of a lymphocyte surface receptor for low density lipoprotein inhibitor, an immunoregulatory species of normal human serum low density lipoprotein.Journal of Clinical Investigation, 1978
- Transfer of phosphatidylcholine facilitated by a component of human plasmaBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1978
- Interactions of native and modified human low density lipoproteins with human skin fibroblastsBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1978
- Regulation of low density lipoprotein receptor activity in freshly isolated human lymphocytes.Journal of Clinical Investigation, 1976
- Stimulation of human erythrocyte Mg++-ATPase by plasma lipoproteinsBiochemical and Biophysical Research Communications, 1975
- Inositol phospholipids and cell surface receptor functionBiochimica et Biophysica Acta (BBA) - Reviews on Biomembranes, 1975
- Mechanism of phytohemagglutinin (PHA) action: V. PHA compared with concanavalin A (Con A)Experimental Cell Research, 1972
- THE DISTRIBUTION AND CHEMICAL COMPOSITION OF ULTRACENTRIFUGALLY SEPARATED LIPOPROTEINS IN HUMAN SERUMJournal of Clinical Investigation, 1955